Skip to main content
Top
Published in: Brain Tumor Pathology 1/2011

01-02-2011 | Case Report

Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence

Authors: Shingo Tanaka, Mitsutoshi Nakada, Yutaka Hayashi, Satoko Nakada, Seiko Sawada-Kitamura, Natsuki Furuyama, Tomohide Suzuki, Tomoya Kamide, Yasuhiko Hayashi, Seiji Yano, Jun-ichiro Hamada

Published in: Brain Tumor Pathology | Issue 1/2011

Login to get access

Abstract

A 55-year-old man was admitted to our hospital complaining of left hemiparesis. Magnetic resonance imaging (MRI) showed a smooth ring-like enhanced cystic tumor in the right parietal lobe. He underwent gross total resection of the tumor under neuronavigation and 5-aminolevulinic acid (5-ALA) fluorescence guiding method. Histopathological examination of the tumor showed small cells formed epithelioid solid nests with some focus of duct-like structure. On the basis of the MRI and operative and histological findings, this tumor was diagnosed as a metastatic poorly differentiated carcinoma, although the primary cancer could not be detected by metastatic work-ups. Afterward, this tumor recurred repeatedly. Histopathological examination of specimen from the fourth surgery indicated that the tumor was a glioblastoma (GBM). In the review of the histology and immunohistochemistry of the first tumor, atypical fibrillary cells were seen between solid nests and positive for glial fibrillary acidic protein, therefore the tumor was retrospectively diagnosed as epithelioid GBM. We assessed whether the changes in histopathology were accompanied by changes in the methylation status of O6-methylguanine methyltransferase (MGMT) promoter and the status of 5-ALA fluorescence. The methylation status of the MGMT promoter was found to have changed from methylated to unmethylated and 5-ALA fluorescence became positive along with the histological change.
Literature
1.
go back to reference Kepes JJ, Fulling KH, Garcia JH (1982) The clinical significance of “adenoid” formations of neoplastic astrocytes, imitating metastatic carcinoma, in gliosarcomas. A review of five cases. Clin Neuropathol 1:139–150PubMed Kepes JJ, Fulling KH, Garcia JH (1982) The clinical significance of “adenoid” formations of neoplastic astrocytes, imitating metastatic carcinoma, in gliosarcomas. A review of five cases. Clin Neuropathol 1:139–150PubMed
2.
go back to reference Akimoto J, Namatame H, Haraoka J et al (2005) Epithelioid glioblastoma: a case report. Brain Tumor Pathol 22:21–27CrossRefPubMed Akimoto J, Namatame H, Haraoka J et al (2005) Epithelioid glioblastoma: a case report. Brain Tumor Pathol 22:21–27CrossRefPubMed
3.
go back to reference Miyata S, Sugimoto T, Kodama T et al (2005) Adenoid glioblastoma arising in a patient with neurofibromatosis type-1. Pathol Int 55:348–352CrossRefPubMed Miyata S, Sugimoto T, Kodama T et al (2005) Adenoid glioblastoma arising in a patient with neurofibromatosis type-1. Pathol Int 55:348–352CrossRefPubMed
4.
go back to reference Mork SJ, Rubinstein LJ, Kepes JJ (1988) Patterns of epithelial metaplasia in malignant gliomas. I. Papillary formations mimicking medulloepithelioma. J Neuropathol Exp Neurol 47:93–100CrossRefPubMed Mork SJ, Rubinstein LJ, Kepes JJ (1988) Patterns of epithelial metaplasia in malignant gliomas. I. Papillary formations mimicking medulloepithelioma. J Neuropathol Exp Neurol 47:93–100CrossRefPubMed
5.
go back to reference Mork SJ, Rubinstein LJ, Kepes JJ et al (1988) Patterns of epithelial metaplasia in malignantgliomas. II. Squamous differentiation of epithelial-like formations in gliosarcomas and glioblastomas. J Neuropathol Exp Neurol 47:101–118CrossRefPubMed Mork SJ, Rubinstein LJ, Kepes JJ et al (1988) Patterns of epithelial metaplasia in malignantgliomas. II. Squamous differentiation of epithelial-like formations in gliosarcomas and glioblastomas. J Neuropathol Exp Neurol 47:101–118CrossRefPubMed
6.
go back to reference Shintaku M, Hirano A, Llena JF (1988) Fine structure of glioblastoma multiforme with “adenoid formation”. No Shinkei Geka 16:997–1003PubMed Shintaku M, Hirano A, Llena JF (1988) Fine structure of glioblastoma multiforme with “adenoid formation”. No Shinkei Geka 16:997–1003PubMed
7.
go back to reference Shintaku M, Nakatsu S, Okamoto S (2000) “Adenoid” glioblastoma. No Shinkei Geka 28:359–365PubMed Shintaku M, Nakatsu S, Okamoto S (2000) “Adenoid” glioblastoma. No Shinkei Geka 28:359–365PubMed
8.
go back to reference Rodriguez FJ, Scheithauer BW, Giannini C et al (2008) Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer 113:2779–2789CrossRefPubMed Rodriguez FJ, Scheithauer BW, Giannini C et al (2008) Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer 113:2779–2789CrossRefPubMed
9.
go back to reference Kamide T, Nakada M, Hayashi Y et al (2010) Radiation-induced cerebellar high-grade glioma accompanied by meningioma and cavernoma 29 years after the treatment of medulloblastoma: a case report. J Neurooncol 2010 Mar 31 [Epub ahead of print] Kamide T, Nakada M, Hayashi Y et al (2010) Radiation-induced cerebellar high-grade glioma accompanied by meningioma and cavernoma 29 years after the treatment of medulloblastoma: a case report. J Neurooncol 2010 Mar 31 [Epub ahead of print]
10.
go back to reference Palmisano WA, Divine KK, Saccomanno G et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954–5958PubMed Palmisano WA, Divine KK, Saccomanno G et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954–5958PubMed
11.
go back to reference Yoshida Y, Nakada M, Sugimoto N et al (2010) Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival. Int J Cancer 126:2341–2352PubMed Yoshida Y, Nakada M, Sugimoto N et al (2010) Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival. Int J Cancer 126:2341–2352PubMed
12.
go back to reference Ozolek JA, Finkelstein SD, Couce ME (2004) Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol 17:739–745CrossRefPubMed Ozolek JA, Finkelstein SD, Couce ME (2004) Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol 17:739–745CrossRefPubMed
13.
go back to reference Balasubramaniam A, Shannon P, Hodaie M et al (2007) Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro Oncol 9:447–453CrossRefPubMed Balasubramaniam A, Shannon P, Hodaie M et al (2007) Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro Oncol 9:447–453CrossRefPubMed
14.
go back to reference Pistollato F, Abbadi S, Rampazzo E et al (2010) Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 28(5):851–862PubMed Pistollato F, Abbadi S, Rampazzo E et al (2010) Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 28(5):851–862PubMed
15.
go back to reference Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401CrossRefPubMed Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401CrossRefPubMed
16.
go back to reference Zhang M, Song T, Yang L et al (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27:85CrossRefPubMed Zhang M, Song T, Yang L et al (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27:85CrossRefPubMed
17.
go back to reference Strojnik T, Rosland GV, Sakariassen PO et al (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68:133–143CrossRefPubMed Strojnik T, Rosland GV, Sakariassen PO et al (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68:133–143CrossRefPubMed
18.
go back to reference Tamura K, Aoyagi M, Wakimoto H et al (2010) Accumulation of CD133-positive glioma cells after high-dose irradiation by gamma knife surgery plus external beam radiation. J Neurosurg 113:310–318CrossRefPubMed Tamura K, Aoyagi M, Wakimoto H et al (2010) Accumulation of CD133-positive glioma cells after high-dose irradiation by gamma knife surgery plus external beam radiation. J Neurosurg 113:310–318CrossRefPubMed
19.
go back to reference Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed
20.
go back to reference Brandes AA, Franceschi E, Tosoni A et al (2010) O(6)-Methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neuro Oncol 12:283–288PubMed Brandes AA, Franceschi E, Tosoni A et al (2010) O(6)-Methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neuro Oncol 12:283–288PubMed
21.
go back to reference Parkinson JF, Wheeler HR, Clarkson A et al (2008) Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. J Neurooncol 87:71–78CrossRefPubMed Parkinson JF, Wheeler HR, Clarkson A et al (2008) Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. J Neurooncol 87:71–78CrossRefPubMed
22.
go back to reference Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401CrossRefPubMed Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401CrossRefPubMed
23.
go back to reference Stummer W, Novotny A, Stepp H et al (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013CrossRefPubMed Stummer W, Novotny A, Stepp H et al (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013CrossRefPubMed
24.
go back to reference Utsuki S, Miyoshi N, Oka H et al (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24:53–55CrossRefPubMed Utsuki S, Miyoshi N, Oka H et al (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24:53–55CrossRefPubMed
Metadata
Title
Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence
Authors
Shingo Tanaka
Mitsutoshi Nakada
Yutaka Hayashi
Satoko Nakada
Seiko Sawada-Kitamura
Natsuki Furuyama
Tomohide Suzuki
Tomoya Kamide
Yasuhiko Hayashi
Seiji Yano
Jun-ichiro Hamada
Publication date
01-02-2011
Publisher
Springer Japan
Published in
Brain Tumor Pathology / Issue 1/2011
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-010-0009-x

Other articles of this Issue 1/2011

Brain Tumor Pathology 1/2011 Go to the issue